More on CNSY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.03 |
|
|||
| Open | $2.03 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $2.06 | ||||
| Day Low | $1.90 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 112,451 | ||||
- Form D CERENOME, INC.
- Cerenome names Samantha Fowlkes VP of commercial sales at CNSide
- Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
- Form 8-K CERENOME, INC. For: Sep 04
- Cerenome secures $20M financing deal with royalty-based repayments
- Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
- Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines
- Form 10-Q CERENOME, INC. For: Jun 30
- Form 8-K CERENOME, INC. For: Aug 14
- Cerenome Reports Second Quarter 2026 Financial Results and Business Update
